help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krajewska, M.
Right arrow Articles by Reed, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krajewska, M.
Right arrow Articles by Reed, J. C.

American Journal of Pathology, Vol 148, 1567-1576, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers

M Krajewska, S Krajewski, JI Epstein, A Shabaik, J Sauvageot, K Song, S Kitada and JC Reed
Burnham Institute, La Jolla, California 92037, USA.

Proteins encoded by bcl-2 family genes are important regulators of programmed cell death and apoptosis. Alterations in the expression of these apoptosis-regulating genes can contribute to the origins of cancer, as well as adversely influence tumor responses to chemo- and radiotherapy. Using antibodies specific for the Bcl-2, Bax, Bcl-X, and Mcl-1 proteins in combination with immunohistochemical methods, we examined for the first time the expression of these bcl-2 family genes in 64 cases of adenocarcinoma of the prostate, including 10 Gleason grade 2 to 4 tumors, 21 grade 5 to 7 tumors, 17 grade 8 to 10 tumors, 8 lymph node metastases, and 8 bone metastases. In addition, 24 cases of prostatic intraepithelial neoplasia (PIN) or PIN coexisting with carcinoma were also evaluated. All immunostaining results were scored with regard to approximate percentage of positive tumor cells and relative immunostaining intensity. Expression of the anti-apoptotic protein Bcl-2 was present in 16 of 64 (25%) adenocarcinomas and tended to be more frequent in high grade tumors (Gleason grade 8 to 10; 41%) and nodal metastases (38%) than in lower grade (Gleason 2 to 7) primary tumors (16%; P < 0.05). Bcl-X was expressed in all 64 (100%) tumors evaluated. Bcl-X immunointensity was generally stronger in high grade primary tumors (grade 8 to 10) and metastases compared with PIN and low grade neoplasms (P < 0.0001). In addition, the proportion of specimens with > 50% Bcl-X-immunopositive tumor cells also was higher in advanced grade primary tumors (Gleason 8 to 10) and metastases than in PIN and low grade tumors (Gleason 2 to 7; P < 0.005). The anti-apoptotic protein Mcl-1 was expressed in 52 of 64 (81%) tumors, compared with only 9 of 24 (38%) cases of PIN (P < 0.001). In addition, the percentage of Mcl-1-positive cells was typically higher in Gleason grade 8 to 10 tumors and metastases than in PIN or lower grade tumors (P = 0.025). In contrast, the pro-apoptotic protein Bax was expressed in all prostate cancers evaluated, with high percentages of immunopositive cells and strong immunointensity typically occurring regardless of tumor grade. The findings suggest that expression of several anti-apoptotic members of the bcl-2 gene family, including bcl- 2, bcl-X, and mcl-1 increases during progression of prostate cancers, a finding that may be relevant to the hormone-insensitive, metastatic phenotype of most advanced adenocarcinomas of the prostate.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
P. Cloutier, J. Toutant, L. Shkreta, S. Goekjian, T. Revil, and B. Chabot
Antagonistic Effects of the SRp30c Protein and Cryptic 5 ' Splice Sites on the Alternative Splicing of the Apoptotic Regulator Bcl-x
J. Biol. Chem., August 1, 2008; 283(31): 21315 - 21324.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. Meng, W. Tang, Y. Dai, X. Wu, M. Liu, Q. Ji, M. Ji, K. Pienta, T. Lawrence, and L. Xu
Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa
Mol. Cancer Ther., July 1, 2008; 7(7): 2192 - 2202.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J.-S. Diallo, A. Aldejmah, A. F. Mouhim, B. Peant, M. A. Fahmy, I. H. Koumakpayi, K. Sircar, L. R. Begin, A.-M. Mes-Masson, and F. Saad
NOXA and PUMA Expression Add to Clinical Markers in Predicting Biochemical Recurrence of Prostate Cancer Patients in a Survival Tree Model
Clin. Cancer Res., December 1, 2007; 13(23): 7044 - 7052.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Kobayashi, S.-H. Lee, X. W. Meng, J. L. Mott, S. F. Bronk, N. W. Werneburg, R. W. Craig, S. H. Kaufmann, and G. J. Gores
Serine 64 Phosphorylation Enhances the Antiapoptotic Function of Mcl-1
J. Biol. Chem., June 22, 2007; 282(25): 18407 - 18417.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Y. Khor, J. Moughan, T. Al-Saleem, E. H. Hammond, V. Venkatesan, S. A. Rosenthal, M. A. Ritter, H. M. Sandler, G. E. Hanks, W. U. Shipley, et al.
Bcl-2 and Bax Expression Predict Prostate Cancer Outcome in Men Treated with Androgen Deprivation and Radiotherapy on Radiation Therapy Oncology Group Protocol 92-02
Clin. Cancer Res., June 15, 2007; 13(12): 3585 - 3590.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Sarkar, I. V. Lebedeva, Z.-z. Su, E.-S. Park, L. Chatman, N. Vozhilla, P. Dent, D. T. Curiel, and P. B. Fisher
Eradication of Therapy-Resistant Human Prostate Tumors Using a Cancer Terminator Virus
Cancer Res., June 1, 2007; 67(11): 5434 - 5442.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Castilla, B. Congregado, D. Chinchon, F. J. Torrubia, M. A. Japon, and C. Saez
Bcl-xL Is Overexpressed in Hormone-Resistant Prostate Cancer and Promotes Survival of LNCaP Cells via Interaction with Proapoptotic Bak
Endocrinology, October 1, 2006; 147(10): 4960 - 4967.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. J. Riemenschneider, R. A. Betensky, S. M. Pasedag, and D. N. Louis
AKT Activation in Human Glioblastomas Enhances Proliferation via TSC2 and S6 Kinase Signaling
Cancer Res., June 1, 2006; 66(11): 5618 - 5623.
[Abstract] [Full Text] [PDF]

Home page
 Protein Eng Des SelHome page
K. Jonas, E. Van Der Vries, M. T.I. Nilsson, and M. Widersten
Isolation of novel single-chain Cro proteins targeted for binding to the bcl-2 transcription initiation site by repertoire selection and subunit combinatorics
Protein Eng. Des. Sel., November 1, 2005; 18(11): 537 - 546.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Yamanaka, P. Rocchi, H. Miyake, L. Fazli, B. Vessella, U. Zangemeister-Wittke, and M. E. Gleave
A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells
Mol. Cancer Ther., November 1, 2005; 4(11): 1689 - 1698.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. J.M. Best, J. W. Gillespie, Y. Yi, G. V.R. Chandramouli, M. A. Perlmutter, Y. Gathright, H. S. Erickson, L. Georgevich, M. A. Tangrea, P. H. Duray, et al.
Molecular Alterations in Primary Prostate Cancer after Androgen Ablation Therapy
Clin. Cancer Res., October 1, 2005; 11(19): 6823 - 6834.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
C Hughes, A Murphy, C Martin, O Sheils, and J O'Leary
Molecular pathology of prostate cancer
J. Clin. Pathol., July 1, 2005; 58(7): 673 - 684.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Garneau, T. Revil, J.-F. Fisette, and B. Chabot
Heterogeneous Nuclear Ribonucleoprotein F/H Proteins Modulate the Alternative Splicing of the Apoptotic Mediator Bcl-x
J. Biol. Chem., June 17, 2005; 280(24): 22641 - 22650.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Chandra, G. Choy, P. T. Daniel, and D. G. Tang
Bax-dependent Regulation of Bak by Voltage-dependent Anion Channel 2
J. Biol. Chem., May 13, 2005; 280(19): 19051 - 19061.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. Wang, A. Bergh, and J.-E. Damber
Cyclooxygenase-2 Expression Correlates with Local Chronic Inflammation and Tumor Neovascularization in Human Prostate Cancer
Clin. Cancer Res., May 1, 2005; 11(9): 3250 - 3256.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Hussain, N. Dawson, P. Amin, C. Engstrom, B. Dorsey, E. Siegel, and C. Guo
Docetaxel Followed by Hormone Therapy in Men Experiencing Increasing Prostate-Specific Antigen After Primary Local Treatments for Prostate Cancer
J. Clin. Oncol., April 20, 2005; 23(12): 2789 - 2796.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
X. Liao, S. Tang, J. B. Thrasher, T. L. Griebling, and B. Li
Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer
Mol. Cancer Ther., April 1, 2005; 4(4): 505 - 515.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-P. Piret, E. Minet, J.-P. Cosse, N. Ninane, C. Debacq, M. Raes, and C. Michiels
Hypoxia-inducible Factor-1-dependent Overexpression of Myeloid Cell Factor-1 Protects Hypoxic Cells against tert-Butyl Hydroperoxide-induced Apoptosis
J. Biol. Chem., March 11, 2005; 280(10): 9336 - 9344.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
L. Xu, D. Yang, S. Wang, W. Tang, M. Liu, M. Davis, J. Chen, J. M. Rae, T. Lawrence, and M. E. Lippman
(-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer
Mol. Cancer Ther., February 1, 2005; 4(2): 197 - 205.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
G. M. Carbone, S. Napoli, A. Valentini, F. Cavalli, D. K. Watson, and C. V. Catapano
Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells
Nucleic Acids Res., August 16, 2004; 32(14): 4358 - 4367.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. An, Y. Chen, and Z. Huang
Critical Upstream Signals of Cytochrome c Release Induced by a Novel Bcl-2 Inhibitor
J. Biol. Chem., April 30, 2004; 279(18): 19133 - 19140.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. A. Heinlein and C. Chang
Androgen Receptor in Prostate Cancer
Endocr. Rev., April 1, 2004; 25(2): 276 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Grzmil, P. Thelen, B. Hemmerlein, S. Schweyer, S. Voigt, D. Mury, and P. Burfeind
Bax Inhibitor-1 Is Overexpressed in Prostate Cancer and Its Specific Down-Regulation by RNA Interference Leads to Cell Death in Human Prostate Carcinoma Cells
Am. J. Pathol., August 1, 2003; 163(2): 543 - 552.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Ding, Y. Shimada, M. Maeda, A. Kawabe, J. Kaganoi, I. Komoto, Y. Hashimoto, M. Miyake, H. Hashida, and M. Imamura
Association of CC Chemokine Receptor 7 with Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma
Clin. Cancer Res., August 1, 2003; 9(9): 3406 - 3412.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Y. Y. Fong, R. Mancini, H. Nakagawa, A. K. Rustgi, and K. Huebner
Combined Cyclin D1 Overexpression and Zinc Deficiency Disrupts Cell Cycle and Accelerates Mouse Forestomach Carcinogenesis
Cancer Res., July 15, 2003; 63(14): 4244 - 4252.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. Shim, M. L. Gauthier, D. Sudilovsky, K. Mantei, K. L. Chew, D. H. Moore, I. Cha, T. D. Tlsty, and L. J. Esserman
Cyclooxygenase-2 Expression Is Related to Nuclear Grade in Ductal Carcinoma in Situ and Is Increased in Its Normal Adjacent Epithelium
Cancer Res., May 15, 2003; 63(10): 2347 - 2350.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
M. Dore, I. Lanthier, and J. Sirois
Cyclooxygenase-2 Expression in Canine Mammary Tumors
Vet. Pathol., March 1, 2003; 40(2): 207 - 212.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. R. Mercatante, J. L. Mohler, and R. Kole
Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents
J. Biol. Chem., December 13, 2002; 277(51): 49374 - 49382.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. L. Tran, D. G. Adams, R. R. Vaillancourt, and R. L. Heimark
Signal Transduction from N-cadherin Increases Bcl-2. REGULATION OF THE PHOSPHATIDYLINOSITOL 3-KINASE/Akt PATHWAY BY HOMOPHILIC ADHESION AND ACTIN CYTOSKELETAL ORGANIZATION
J. Biol. Chem., August 30, 2002; 277(36): 32905 - 32914.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Half, X. M. Tang, K. Gwyn, A. Sahin, K. Wathen, and F. A. Sinicrope
Cyclooxygenase-2 Expression in Human Breast Cancers and Adjacent Ductal Carcinoma in Situ
Cancer Res., March 1, 2002; 62(6): 1676 - 1681.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. J. Morris, W. P. Tong, C. Cordon-Cardo, M. Drobnjak, W. K. Kelly, S. F. Slovin, K. L. Terry, K. Siedlecki, P. Swanson, M. Rafi, et al.
Phase I Trial of BCL-2 Antisense Oligonucleotide (G3139) Administered by Continuous Intravenous Infusion in Patients with Advanced Cancer
Clin. Cancer Res., March 1, 2002; 8(3): 679 - 683.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Ruiz, P. Troncoso, C. Bruns, and M. Bar-Eli
Activator Protein 2{alpha} Transcription Factor Expression Is Associated with Luminal Differentiation and Is Lost in Prostate Cancer
Clin. Cancer Res., December 1, 2001; 7(12): 4086 - 4095.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
L. Y. Y. Fong, V. T. Nguyen, and J. L. Farber
Esophageal Cancer Prevention in Zinc-Deficient Rats: Rapid Induction of Apoptosis by Replenishing Zinc
J Natl Cancer Inst, October 17, 2001; 93(20): 1525 - 1533.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Huang, J. C. Cheville, Y. Pan, P. C. Roche, L. J. Schmidt, and D. J. Tindall
PTEN Induces Chemosensitivity in PTEN-mutated Prostate Cancer Cells by Suppression of Bcl-2 Expression
J. Biol. Chem., October 12, 2001; 276(42): 38830 - 38836.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M. Matsumoto, S. Natsugoe, S. Nakashima, H. Okumura, H. Sakita, M. Baba, S. Takao, and T. Aikou
Clinical Significance and Prognostic Value of Apoptosis Related Proteins in Superficial Esophageal Squamous Cell Carcinoma
Ann. Surg. Oncol., August 1, 2001; 8(7): 598 - 604.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
O. Gautschi, S. Tschopp, R. A. Olie, S. H. Leech, A. P. Simoes-Wust, A. Ziegler, B. Baumann, B. Odermatt, J. Hall, R. A. Stahel, et al.
Activity of a Novel bcl-2/bcl-xL-Bispecific Antisense Oligonucleotide Against Tumors of Diverse Histologic Origins
J Natl Cancer Inst, March 21, 2001; 93(6): 463 - 471.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Kulik, J. P. Carson, T. Vomastek, K. Overman, B. D. Gooch, S. Srinivasula, E. Alnemri, G. Nunez, and M. J. Weber
Tumor Necrosis Factor {{alpha}} Induces BID Cleavage and Bypasses Antiapoptotic Signals in Prostate Cancer LNCaP Cells
Cancer Res., March 1, 2001; 61(6): 2713 - 2719.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
I. Lebedeva, R. Rando, J. Ojwang, P. Cossum, and C. A. Stein
Bcl-xL in Prostate Cancer Cells: Effects of Overexpression and Down-Regulation on Chemosensitivity
Cancer Res., November 1, 2000; 60(21): 6052 - 6060.
[Abstract] [Full Text]

Home page
 Genes Dev.Home page
C. Abate-Shen and M. M. Shen
Molecular genetics of prostate cancer
Genes & Dev., October 1, 2000; 14(19): 2410 - 2434.
[Full Text]

Home page
 Clin. Cancer Res.Home page
A. Khabir, A. Sellami, M. Sakka, A. M. Ghorbel, J. Daoud, M. Frikha, M. M. Drira, P. Busson, and R. Jlidi
Contrasted Frequencies of p53 Accumulation in the Two Age Groups of North African Nasopharyngeal Carcinomas
Clin. Cancer Res., October 1, 2000; 6(10): 3932 - 3936.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
T. Joki, O. Heese, D. C. Nikas, L. Bello, J. Zhang, S.-K. Kraeft, N. T. Seyfried, T. Abe, L. B. Chen, R. S. Carroll, et al.
Expression of Cyclooxygenase 2 (COX-2) in Human Glioma and in Vitro Inhibition by a Specific COX-2 Inhibitor, NS-398
Cancer Res., September 1, 2000; 60(17): 4926 - 4931.
[Abstract] [Full Text]

Home page
 Mol. Cell. Biol.Home page
C. Chen, L. C. Edelstein, and C. Gélinas
The Rel/NF-kappa B Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-xL
Mol. Cell. Biol., April 15, 2000; 20(8): 2687 - 2695.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
A. Shamma, H. Yamamoto, Y. Doki, J. Okami, M. Kondo, Y. Fujiwara, M. Yano, M. Inoue, N. Matsuura, H. Shiozaki, et al.
Up-Regulation of Cyclooxygenase-2 in Squamous Carcinogenesis of the Esophagus
Clin. Cancer Res., April 1, 2000; 6(4): 1229 - 1238.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
S. E. Blutt, T. J. McDonnell, T. C. Polek, and N. L. Weigel
Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-2
Endocrinology, January 1, 2000; 141(1): 10 - 17.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Liu, C. Page, D. R. Beidler, M. S. Wicha, and G. Nunez
Overexpression of Bcl-xL Promotes Chemotherapy Resistance of Mammary Tumors in a Syngeneic Mouse Model
Am. J. Pathol., December 1, 1999; 155(6): 1861 - 1867.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Soini, V. Kinnula, R. Kaarteenaho-Wiik, E. Kurttila, K. Linnainmaa, and P. Paakko
Apoptosis and Expression of Apoptosis Regulating Proteins bcl-2, mcl-1, bcl-X, and bax in Malignant Mesothelioma
Clin. Cancer Res., November 1, 1999; 5(11): 3508 - 3515.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Craft, C. Chhor, C. Tran, A. Belldegrun, J. DeKernion, O. N. Witte, J. Said, R. E. Reiter, and C. L. Sawyers
Evidence for Clonal Outgrowth of Androgen-independent Prostate Cancer Cells from Androgen-dependent Tumors through a Two-Step Process
Cancer Res., October 1, 1999; 59(19): 5030 - 5036.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Sarbia, C. Loberg, M. Wolter, J. Arjumand, H. Heep, G. Reifenberger, and H. E. Gabbert
Expression of Bcl-2 and Amplification of c-myc Are Frequent in Basaloid Squamous Cell Carcinomas of the Esophagus
Am. J. Pathol., October 1, 1999; 155(4): 1027 - 1032.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Okami, H. Yamamoto, Y. Fujiwara, M. Tsujie, M. Kondo, S. Noura, S. Oshima, H. Nagano, K. Dono, K. Umeshita, et al.
Overexpression of Cyclooxygenase-2 in Carcinoma of the Pancreas
Clin. Cancer Res., August 1, 1999; 5(8): 2018 - 2024.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Venugopal, A. Callaway, and E. G. Snyderwine
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) retards mammary gland involution in lactating Sprague–Dawley rats
Carcinogenesis, July 1, 1999; 20(7): 1309 - 1314.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Koga, Y. Hiromatsu, A. Jimi, S. Toda, N. Koike, and K. Nonaka
Immunohistochemical Analysis of Bcl-2, Bax, and Bak Expression in Thyroid Glands from Patients with Subacute Thyroiditis
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2221 - 2225.
[Abstract] [Full Text]

Home page
 Arch Otolaryngol Head Neck SurgHome page
M. A. Hotz, J. Bosq, P. Zbaeren, J. Reed, G. Schwab, S. Krajewski, P. Brousset, and M. M. Borner
Spontaneous Apoptosis and the Expression of p53 and Bcl-2 Family Proteins in Locally Advanced Head and Neck Cancer
Arch Otolaryngol Head Neck Surg, April 1, 1999; 125(4): 417 - 422.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
J. H. HAGER and D. HANAHAN
Tumor Cells Utilize Multiple Pathways to Down-modulate Apoptosis: Lessons from a Mouse Model of Islet Cell Carcinogenesis
Ann. N.Y. Acad. Sci., January 1, 1999; 887(1): 150 - 163.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. C. Zimmermann, M. Sarbia, A.-A. Weber, F. Borchard, H. E. Gabbert, and K. Schror
Cyclooxygenase-2 Expression in Human Esophageal Carcinoma
Cancer Res., January 1, 1999; 59(1): 198 - 204.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
Y. Soini, P. Paakko, and V-P. Lehto
Histopathological Evaluation of Apoptosis in Cancer
Am. J. Pathol., October 1, 1998; 153(4): 1041 - 1053.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. N. Nupponen, L. Kakkola, P. Koivisto, and T. Visakorpi
Genetic Alterations in Hormone-Refractory Recurrent Prostate Carcinomas
Am. J. Pathol., July 1, 1998; 153(1): 141 - 148.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Ke, A. Godzik, and J. C. Reed
Bcl-B, a Novel Bcl-2 Family Member That Differentially Binds and Regulates Bax and Bak
J. Biol. Chem., April 13, 2001; 276(16): 12481 - 12484.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Zhang, Q. Huang, N. Ke, S. Matsuyama, B. Hammock, A. Godzik, and J. C. Reed
Drosophila Pro-apoptotic Bcl-2/Bax Homologue Reveals Evolutionary Conservation of Cell Death Mechanisms
J. Biol. Chem., August 25, 2000; 275(35): 27303 - 27306.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. R. Mercatante, C. D. Bortner, J. A. Cidlowski, and R. Kole
Modification of Alternative Splicing of Bcl-x Pre-mRNA in Prostate and Breast Cancer Cells. ANALYSIS OF APOPTOSIS AND CELL DEATH
J. Biol. Chem., May 4, 2001; 276(19): 16411 - 16417.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. E. Chipuk, M. Bhat, A. Y. Hsing, J. Ma, and D. Danielpour
Bcl-xL Blocks Transforming Growth Factor-beta 1-induced Apoptosis by Inhibiting Cytochrome c Release and Not by Directly Antagonizing Apaf-1-dependent Caspase Activation in Prostate Epithelial Cells
J. Biol. Chem., July 6, 2001; 276(28): 26614 - 26621.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G.-Q. Wang, B. R. Gastman, E. Wieckowski, L. A. Goldstein, A. Gambotto, T.-H. Kim, B. Fang, A. Rabinovitz, X.-M. Yin, and H. Rabinowich
A Role for Mitochondrial Bak in Apoptotic Response to Anticancer Drugs
J. Biol. Chem., August 31, 2001; 276(36): 34307 - 34317.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.